Promapar en es it fr

Promapar Brand names, Promapar Analogs

Promapar Brand Names Mixture

  • No information avaliable

Promapar Chemical_Formula


Promapar RX_link

No information avaliable

Promapar fda sheet

Promapar msds (material safety sheet)

Promapar Synthesis Reference

No information avaliable

Promapar Molecular Weight

284.42 g/mol

Promapar Melting Point

< 25 oC

Promapar H2O Solubility

14.2 mg/L

Promapar State


Promapar LogP


Promapar Dosage Forms

Tablet; Oral liquid; Injection

Promapar Indication

Used as an adjunct for short term treatment of moderate and severe psychomotor agitation. Also used to treat agitation or restlessness in the elderly.

Promapar Pharmacology

Promazine belongs to a group of medications known as the phenothiazine antipsychotics. It acts by blocking a variety of receptors in the brain, particularly dopamine receptors. Dopamine is involved in transmitting signals between brain cells. When there is an excess amount of dopamine in the brain it causes over-stimulation of dopamine receptors. These receptors normally act to modify behaviour and over-stimulation may result in psychotic illness. Promazine hydrochloride blocks these receptors and stops them becoming over-stimulated, thereby helping to control psychotic illness. Promazine has weak extrapyramidal and autonomic side effects which lead to its use in the elderly, for restless or psychotic patients. Its anti-psychotic effect is also weaker and it is not useful in general psychiatry.

Promapar Absorption

Absorption may be erratic and peak plasma concentrations show large interindividual differences.

Promapar side effects and Toxicity

Side effects include: extrapyramidal symptoms, drowsiness, weight gain, dry mouth, constipation, endocrine effects (such as gynaecomastia and menstrual disturbance), sensitivity to sunlight and haemolytic anaemia.

Promapar Patient Information

No information avaliable

Promapar Organisms Affected

Humans and other mammals